Efficacy and Safety of Semaglutide for the Management of Obese Patients With Type 2 Diabetes and Chronic Heart Failure in Real-World Clinical Practice

BACKGROUND: The impact of glucagon-like peptide-1 receptor agonists on patients with heart failure has not been fully described. Our main objective was to evaluate the safety and clinical and glycemic efficacy of once-weekly semaglutide in obese patients with type 2 diabetes and heart failure. METHO...

Descripción completa

Detalles Bibliográficos
Autores principales: Pérez-Belmonte, Luis M., Sanz-Cánovas, Jaime, García de Lucas, María D., Ricci, Michele, Avilés-Bueno, Beatriz, Cobos-Palacios, Lidia, Pérez-Velasco, Miguel A., López-Sampalo, Almudena, Bernal-López, M. Rosa, Jansen-Chaparro, Sergio, Miramontes-González, José P., Gómez-Huelgas, Ricardo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Endocrinology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9263111/
https://www.ncbi.nlm.nih.gov/pubmed/35813629
http://dx.doi.org/10.3389/fendo.2022.851035

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9263111/
https://www.ncbi.nlm.nih.gov/pubmed/35813629
http://dx.doi.org/10.3389/fendo.2022.851035

Ejemplares similares